Lili Wang
Impact in
- Genetics top 0.1%
- Virus-based gene therapy research
- Molecular Biology top 0.2%
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Viral Infectious Diseases and Gene Expression in Insects
- Retinal Development and Disorders
Papers in
- Aging 8
-
- RNA Interference and Gene Delivery 39
- CRISPR and Genetic Engineering 33
- Co-authors
- James M. WilsonRoberto CalcedoGuangping GaoPeter BellJulie JohnstonMauricio R. AlviraKaren DuffInder M. Verma
- Journals
- PLoS ONE (14 papers)Molecular Therapy (11 papers)Blood (10 papers)Human Gene Therapy (9 papers)Proceedings of the National Academy of Sciences (8 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lili Wang
499 papers receiving 18.7k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Genetics 6.0k
- Molecular Biology 11.2k
- Aging 175
- Physiology 2.4k
- Cardiology and Cardiovascular Medicine 1.8k
Countries citing papers authored by Lili Wang
This map shows the geographic impact of Lili Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Wang more than expected).
Fields of papers citing papers by Lili Wang
This network shows the impact of papers produced by Lili Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Wang. The network helps show where Lili Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lili Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 23 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 73 | |
| 8 | 2022 | 22 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 6 | |
| 12 | Resveratrol Protects Osteoblasts Against Dexamethasone-Induced Cytotoxicity Through Activation of AMP-Activated Protein Kinase | 2020 | 2 |
| 13 | 2020 | 14 | |
| 14 | 2020 | 175 | |
| 15 | Significant prognostic values of aquaporin mRNA expression in breast cancer | 2019 | 5 |
| 16 | 2018 | 12 | |
| 17 | 2009 | 1 | |
| 18 | A Robust Algorithm for Copy Number Detection Using High-Density Oligonucleotide Single Nucleotide Polymorphism Genotyping Arrays Hit paper breakdown → | 2005 | 501 |
| 19 | 2002 | 20 | |
| 20 | 2002 | 288 |
About Lili Wang
Lili Wang is a scholar working on Aging, Molecular Biology, Genetics, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 525 papers that have together received 19.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (59 papers), RNA Interference and Gene Delivery (39 papers), CRISPR and Genetic Engineering (33 papers), Viral Infections and Immunology Research (24 papers), Viral gastroenteritis research and epidemiology (21 papers), Adipose Tissue and Metabolism (18 papers), Plant Molecular Biology Research (16 papers) and CAR-T cell therapy research (16 papers). The work is most often cited by research in Genetics (6.0k citations), Molecular Biology (11.2k citations), Aging (175 citations), Physiology (2.4k citations) and Cardiology and Cardiovascular Medicine (1.8k citations). Lili Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include James M. Wilson, Roberto Calcedo, Guangping Gao, Peter Bell, Julie Johnston, Mauricio R. Alvira, Karen Duff, Inder M. Verma, Emmanuel Planel and Hiroki Morizono. Their work appears in journals such as PLoS ONE, Molecular Therapy, Blood, Human Gene Therapy and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.